Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Primary Neoplasms of the Seminal Vesicles: A Narrative Review of Carcinoma and the Rarer Non-Epithelial and Biphasic Tumours. | Diagnostics (Basel) | 2026 | 42793728 | PubTator, text mining | PubMed |
| NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor. | Semin Oncol | 2026 | 42762807 | PubTator, text mining | PubMed |
| Urothelial carcinoma of the bladder with prostatic stromal invasion and early postoperative bone metastases: a case report. | Front Urol | 2026 | 42698475 | PubTator, text mining | PubMed |
| Occult Esophageal Squamous Cell Carcinoma Presenting as Bone-Predominant Carcinoma of Unknown Primary: A Case Report of a p40-Negative Vertebral Metastasis. | Diagnostics (Basel) | 2026 | 42651078 | PubTator, text mining | PubMed |
| Reappraisal of Endobronchial Polypoid Adenocarcinoma of the Lung: A Clinicopathological Analysis of 11 Cases. | Am J Surg Pathol | 2026 | 42638334 | PubTator, text mining | PubMed |
| Post-translational modifications in prostate cancer: coordinated oncogenic networks and clinical implications. | Biochim Biophys Acta Rev Cancer | 2026 | 42637058 | PubTator, text mining | PubMed |
| Occult Metastatic Prostate Carcinoma Presenting With Decompensated Heart Failure and Bicytopenia. | Cureus | 2026 | 42597963 | PubTator, text mining | PubMed |
| Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on 18F-FDG PET/CT During Treatment for Metastases After 10 Years of Remission. | Case Rep Radiol | 2026 | 42569055 | PubTator, text mining | PubMed |
| Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells. | Front Oncol | 2026 | 42568401 | PubTator, text mining | PubMed |
| Prostate Cancer Associated with Muir-Torre Syndrome: A Rare Case Report and Literature Review. | Case Rep Oncol | 2026 | 42541269 | PubTator, text mining | PubMed |
| Diagnostic and Clinicopathological Utility of High-Molecular-Weight Cytokeratin (HMWCK) and NKX3.1 Immunohistochemistry in Prostatic Adenocarcinoma. | Cureus | 2026 | 42519281 | PubTator, text mining | PubMed |
| GPR56 regulates the expression of key androgen-target genes via G13-Rho-PKN1 axis and is overexpressed in prostate cancer. | J Steroid Biochem Mol Biol | 2026 | 42498205 | PubTator, text mining | PubMed |
| Seminal Vesicle Mass Fistulising to the Rectum: A Rare Urological Presentation of Lung Cancer Metastasis. | Reports (MDPI) | 2026 | 42496510 | PubTator, text mining | PubMed |
| Adenocarcinoma with endometrioid features originating in the male genitourinary tract after hormonal therapy for prostate cancer. | Int Cancer Conf J | 2026 | 42491161 | PubTator, text mining | PubMed |
| Generation of synthetic vascular organoids via orthogonal programming of human pluripotent stem cells. | Cell Regen | 2026 | 42446805 | PubTator, text mining | PubMed |
| Penile median raphe cysts: A multicenter retrospective clinicopathological and immunohistochemical study. | Ann Diagn Pathol | 2026 | 42419126 | PubTator, text mining | PubMed |
| Prostate Cancer: Etiology, Diagnosis, and Treatment. | Serican J Med | 2026 | 42375929 | PubTator, text mining | PubMed |
| Clinico-genomic nomograms for estimation of survival risk in metastatic castrate-resistant prostate cancer. | JNCI Cancer Spectr | 2026 | 42231792 | PubTator, text mining | PubMed |
| Construction of a Breast Cancer Predictive Nomogram Based on Diverse Cell Death Methods and Reveal Tumor Microenvironment Characterization. | J Biochem Mol Toxicol | 2026 | 42224434 | PubTator, text mining | PubMed |
| FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate. | Histopathology | 2026 | 42098986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers